IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer

Cell

Volumn 118, Issue 3, 2004, Pages 285-296

  Greten, Florian R ^a   Eckmann, Lars ^a   Greten, Tim F ^b   Park, Jin Mo ^a   Li, Zhi Wei ^a,c   Egan, Laurence J ^a,d   Kagnoff, Martin F ^a   Karin, Michael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; CHUK PROTEIN, MOUSE; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, MOUSE; PROTEIN SERINE THREONINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INCIDENCE; CANCER MODEL; CARCINOGENESIS; CELL TYPE; COLITIS; COLON CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE DELETION; INFLAMMATION; INTESTINE EPITHELIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR PROMOTION; TUMOR VOLUME; ANIMAL; BONE MARROW CELL; COLON TUMOR; ENZYMOLOGY; INTESTINE CELL; METABOLISM; PHYSIOLOGY;

ANIMALIA;

ANIMALS; APOPTOSIS; COLITIS; COLONIC NEOPLASMS; ENTEROCYTES; I-KAPPA B KINASE; INFLAMMATION; MICE; MYELOID CELLS; PROTEIN-SERINE-THREONINE KINASES;

EID: 4043088499     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2004.07.013     Document Type: Article

References (65)

1. Amit S., Ben-Neriah Y. NF-kappaB activation in cancer. a challenge for ubiquitination- and proteasome-based therapeutic approach Semin. Cancer Biol. 13:2003;15-28
2. Balkwill F., Mantovani A. Inflammation and cancer. back to Virchow? Lancet. 357:2001;539-545
3. Barkett M., Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene. 18:1999;6910-6924
4. Barnes P.J., Karin M. Nuclear factor-κB. a pivotal transcription factor in chronic inflammatory diseases N. Engl. J. Med. 336:1997;1066-1071
5. Boivin G.P., Washington K., Yang K., Ward J.M., Pretlow T.P., Russell R., Besselsen D.G., Godfrey V.L., Doetschman T., Dove W.F., et al. Pathology of mouse models of intestinal cancer. consensus report and recommendations Gastroenterology. 124:2003;762-777
6. Cao Y., Bonizzi G., Seagroves T.N., Greten F.R., Johnson R., Schmidt E.V., Karin M. IKKα provides an essential link between RANK signaling and cyclin D1 expression during mammary gland development. Cell. 107:2001;763-775
7. Chen C., Edelstein L.C., Gelinas C. The Rel/NF-κB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol. Cell. Biol. 20:2000;2687-2695
8. Chen L.W., Egan L., Li Z.W., Greten F.R., Kagnoff M.F., Karin M. The two faces of IKK and NF-κB inhibition. prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion Nat. Med. 9:2003;575-581
9. Chung D.C. The genetic basis of colorectal cancer. insights into critical pathways of tumorigenesis Gastroenterology. 119:2000;854-865
10. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8:1999;265-277
11. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 420:2002;860-867
12. Coussens L.M., Tinkle C.L., Hanahan D., Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell. 103:2000;481-490
13. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., Marinkovich M.P., Tao S., Lin Q., Kubo Y., Khavari P.A. NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature. 421:2003;639-643
14. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., Green D.R. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-κB pathways. Immunity. 17:2002;525-535
15. Driscoll K.E., Hassenbein D.G., Howard B.W., Isfort R.J., Cody D., Tindal M.H., Suchanek M., Carter J.M. Cloning, expression, and functional characterization of rat MIP-2. a neutrophil chemoattractant and epithelial cell mitogen J. Leukoc. Biol. 58:1995;359-364
16. Dvorak H.F. Tumors. wounds that do not heal. Similarities between tumor stroma generation and wound healing N. Engl. J. Med. 315:1986;1650-1659
17. Eaden J., Abrams K., Ekbom A., Jackson E., Mayberry J. Colorectal cancer prevention in ulcerative colitis. a case-control study Aliment. Pharmacol. Ther. 14:2000;145-153
18. Eferl R., Ricci R., Kenner L., Zenz R., David J.P., Rath M., Wagner E.F. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell. 112:2003;181-192
19. Egan L.J., Eckmann L., Greten F.R., Chae S., Li Z.W., Myhre G.M., Robine S., Karin M., Kagnoff M.F. IκB-kinasebeta-dependent NF-κB activation provides radioprotection to the intestinal epithelium. Proc. Natl. Acad. Sci. USA. 101:2004;2452-2457
20. Ekbom A. Risk of cancer in ulcerative colitis. J. Gastrointest. Surg. 2:1998;312-313
21. Ghosh S., Karin M. Missing pieces in the NF-κB puzzle. Cell. 109(Suppl):2002;S81-S96
22. Ghosh S., May M.J., Kopp E.B. NF-κB and Rel proteins. evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16:1998;225-260
23. Gilmore T.D. Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel. Oncogene. 18:1999;6925-6937
24. Girnun G.D., Smith W.M., Drori S., Sarraf P., Mueller E., Eng C., Nambiar P., Rosenberg D.W., Bronson R.T., Edelmann W., et al. APC-dependent suppression of colon carcinogenesis by PPARgamma. Proc. Natl. Acad. Sci. USA. 99:2002;13771-13776
25. Gupta R.A., Dubois R.N. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat. Rev. Cancer. 1:2001;11-21
26. Hacker H., Karin M. Is NF-κB2/p100 a direct activator of programmed cell death? Cancer Cell. 2:2002;431-433
27. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
28. Hardwick J.C., van den Brink G.R., Offerhaus G.J., van Deventer S.J., Peppelenbosch M.P. NF-κB, p38 MAPK and JNK are highly expressed and active in the stroma of human colonic adenomatous polyps. Oncogene. 20:2001;819-827
29. He T.C., Chan T.A., Vogelstein B., Kinzler K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 99:1999;335-345
30. Iwamoto M., Koji T., Makiyama K., Kobayashi N., Nakane P.K. Apoptosis of crypt epithelial cells in ulcerative colitis. J. Pathol. 180:1996;152-159
31. Janne P.A., Mayer R.J. Chemoprevention of colorectal cancer. N. Engl. J. Med. 342:2000;1960-1968
32. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination. the control of NF-[kappa]B activity Annu. Rev. Immunol. 18:2000;621-663
33. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227
34. Karin M., Cao Y., Greten F.R., Li Z.W. NF-kappaB in cancer. from innocent bystander to major culprit Nat. Rev. Cancer. 2:2002;301-310
35. Kopp E., Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science. 265:1994;956-959
36. Li Q., Van Antwerp D., Mercurio F., Lee K.F., Verma I.M. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science. 284:1999;321-325. a
37. Li Z.W., Chu W., Hu Y., Delhase M., Deerinck T., Ellisman M., Johnson R., Karin M. The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J. Exp. Med. 189:1999;1839-1845. b
38. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J. Exp. Med. 193:2001;727-740
39. Lind D.S., Hochwald S.N., Malaty J., Rekkas S., Hebig P., Mishra G., Moldawer L.L., Copeland E.M. 3rd, Mackay S. Nuclear factor-kappa B is upregulated in colorectal cancer. Surgery. 130:2001;363-369
40. MacMaster J.F., Dambach D.M., Lee D.B., Berry K.K., Qiu Y., Zusi F.C., Burke J.R. An inhibitor of IkappaB kinase, BMS-345541, blocks endothelial cell adhesion molecule expression and reduces the severity of dextran sulfate sodium-induced colitis in mice. Inflamm. Res. 52:2003;508-511
41. Maeda S., Chang L., Li Z.W., Luo J.L., Leffert H., Karin M. IKKbeta Is Required for Prevention of Apoptosis Mediated by Cell-Bound but Not by Circulating TNFalpha. Immunity. 19:2003;725-737
42. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K.W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 275:1997;1787-1790
43. Morteau O., Morham S.G., Sellon R., Dieleman L.A., Langenbach R., Smithies O., Sartor R.B. Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. J. Clin. Invest. 105:2000;469-478
44. Moser A.R., Pitot H.C., Dove W.F. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science. 247:1990;322-324
45. Munkholm P. Review article. the incidence and prevalence of colorectal cancer in inflammatory bowel disease Aliment. Pharmacol. Ther. 18(Suppl 2):2003;1-5
46. Murano M., Maemura K., Hirata I., Toshina K., Nishikawa T., Hamamoto N., Sasaki S., Saitoh O., Katsu K. Therapeutic effect of intracolonically administered nuclear factor kappa B (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis. Clin. Exp. Immunol. 120:2000;51-58
47. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology. 98:1990;694-702
48. Okayasu I., Ohkusa T., Kajiura K., Kanno J., Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut. 39:1996;87-92
49. Oshima M., Dinchuk J.E., Kargman S.L., Oshima H., Hancock B., Kwong E., Trzaskos J.M., Evans J.F., Taketo M.M. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 87:1996;803-809
50. Park J.M., Greten F.R., Li Z.W., Karin M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science. 297:2002;2048-2051
51. Pasparakis M., Courtois G., Hafner M., Schmidt-Supprian M., Nenci A., Toksoy A., Krampert M., Goebeler M., Gillitzer R., Israel A., et al. TNF-mediated inflammatory skin disease in mice with epidermis-specific deletion of IKK2. Nature. 417:2002;861-866
52. Pegg A.E. Methylation of the O6 position of guanine in DNA is the most likely initiating event in carcinogenesis by methylating agents. Cancer Invest. 2:1984;223-231
53. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Scholmerich J., Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology. 115:1998;357-369
54. Seitz C.S., Lin Q., Deng H., Khavari P.A. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc. Natl. Acad. Sci. USA. 95:1998;2307-2312
55. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science. 293:2001;1495-1499
56. Steinbach G., Lynch P.M., Phillips R.K., Wallace M.H., Hawk E., Gordon G.B., Wakabayashi N., Saunders B., Shen Y., Fujimura T., et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N. Engl. J. Med. 342:2000;1946-1952
57. Tang G., Minemoto Y., Dibling B., Purcell N.H., Li Z., Karin M., Lin A. Inhibition of JNK activation through NF-kappaB target genes. Nature. 414:2001;313-317
58. Toft N.J., Winton D.J., Kelly J., Howard L.A., Dekker M., te Riele H., Arends M.J., Wyllie A.H., Margison G.P., Clarke A.R. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc. Natl. Acad. Sci. USA. 96:1999;3911-3915
59. van Hogerlinden M., Rozell B.L., Ahrlund-Richter L., Toftgard R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 59:1999;3299-3303
60. van Hogerlinden M., Auer G., Toftgard R. Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development. Oncogene. 21:2002;4969-4977
61. Wotherspoon A.C., Ortiz-Hidalgo C., Falzon M.R., Isaacson P.G. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet. 338:1991;1175-1176
62. Yamamoto Y., Yin M.J., Lin K.M., Gaynor R.B. Sulindac inhibits activation of the NF-kappaB pathway. J. Biol. Chem. 274:1999;27307-27314
63. Yin M.J., Yamamoto Y., Gaynor R.B. The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta. Nature. 396:1998;77-80
64. Yu Q., Geng Y., Sicinski P. Specific protection against breast cancers by cyclin D1 ablation. Nature. 411:2001;1017-1021
65. Yu H.G., Yu L.L., Yang Y., Luo H.S., Yu J.P., Meier J.J., Schrader H., Bastian A., Schmidt W.E., Schmitz F. Increased expression of RelA/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology. 65:2003;37-45